Septerna appoints Mark A. Wilson as Chief Legal Officer, effective January 8, 2026

Septerna, Inc.

Mark A. Wilson joins from Nektar Therapeutics, where he was SVP and Chief Legal Officer.
He has over 25 years of experience in IP, corporate legal, and strategic collaborations.
Wilson will oversee legal, IP strategy, and governance for Septerna's GPCR drug discovery pipeline.
He previously led global collaborations and patent strategy at Nektar.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.